林泰新材
920106
C博科测试
301598
中力股份
603194
C蓝宇股份
301585
科隆新材
920098
沪深市场个股详情
688198 佰仁医疗
- 116.05
- 0.000.00%
未开盘 12/23 09:30 (北京)
159.45亿总市值153.91市盈率TTM
0.00最高价0.00最低价0手成交量0.00今开116.05昨收0.00成交额0.00%换手率138.32市盈率(静)1.37亿总股本166.0052周最高13.60市净率159.45亿流通值92.5552周最低139.26涨停价1.37亿流通股234.06历史最高92.84跌停价0.00%振幅20.20历史最低0.80股息TTM--平均价0手内盘0.69%股息率TTM100股每手0手外盘
佰仁医疗关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 13.57%2.92亿 | 13.74%1.91亿 | 17.53%7,626.52万 | 25.57%3.71亿 | 16.60%2.57亿 | 18.95%1.68亿 | -1.69%6,489.16万 | 17.21%2.95亿 | 20.31%2.21亿 | 13.13%1.41亿 |
| 营业收入 | 13.57%2.92亿 | 13.74%1.91亿 | 17.53%7,626.52万 | 25.57%3.71亿 | 16.60%2.57亿 | 18.95%1.68亿 | -1.69%6,489.16万 | 17.21%2.95亿 | 20.31%2.21亿 | 13.13%1.41亿 |
| 营业总成本 | 24.33%2.45亿 | 24.43%1.63亿 | 35.52%7,637.78万 | 28.17%2.7亿 | 21.37%1.97亿 | 26.36%1.31亿 | 7.12%5,635.87万 | -3.87%2.11亿 | 5.40%1.62亿 | 1.98%1.04亿 |
| 营业成本 | 25.83%3,342.79万 | 10.84%2,045.61万 | 8.45%817.25万 | 20.02%3,763.87万 | 17.22%2,656.64万 | 22.94%1,845.61万 | 0.66%753.6万 | 5.92%3,136.09万 | 5.23%2,266.33万 | 7.83%1,501.25万 |
| 营业税金及附加 | 49.26%238.41万 | 68.28%176.19万 | 22.59%53.08万 | 23.81%210.89万 | 22.60%159.73万 | 17.29%104.7万 | -4.89%43.3万 | 38.66%170.33万 | 37.76%130.29万 | 58.54%89.26万 |
| 销售费用 | -1.90%8,173.72万 | -5.97%5,361.08万 | -3.49%2,359.88万 | 0.69%1.01亿 | 8.57%8,332.13万 | 13.51%5,701.44万 | 0.15%2,445.18万 | -9.38%1亿 | -3.48%7,674.22万 | -8.69%5,022.92万 |
| 管理费用 | -2.62%2,240.72万 | -6.12%1,490.31万 | 22.22%819.65万 | 31.65%3,123.52万 | 29.30%2,300.89万 | 51.99%1,587.4万 | 13.26%670.65万 | 14.32%2,372.57万 | 12.17%1,779.47万 | -5.10%1,044.43万 |
| 财务费用 | -898.93%-376.45万 | -991.24%-434.39万 | -2,342.78%-423.02万 | 92.76%-7.04万 | 39.81%-37.69万 | 27.84%-39.81万 | 51.94%-17.32万 | 29.93%-97.18万 | 47.76%-62.61万 | 45.01%-55.17万 |
| -利息费用 | 48.84%35.86万 | 89.42%24.18万 | 653.31%12.11万 | 419.14%41.47万 | 285.84%24.09万 | 205.15%12.77万 | -23.08%1.61万 | -32.64%7.99万 | -34.69%6.24万 | -42.09%4.18万 |
| -利息收入 | -669.74%-478.95万 | -922.66%-468.16万 | -2,016.35%-440.2万 | 29.16%-78.67万 | 15.23%-62.22万 | 25.56%-45.78万 | 47.70%-20.8万 | 28.87%-111.05万 | 45.14%-73.4万 | 44.40%-61.5万 |
| 研发费用 | 72.77%1.09亿 | 95.78%7,706.65万 | 130.45%4,010.94万 | 79.18%9,881.25万 | 41.45%6,308.45万 | 40.96%3,936.46万 | 18.43%1,740.46万 | -6.37%5,514.76万 | 18.95%4,459.94万 | 24.46%2,792.65万 |
| 信用减值损失 | -4.36%-61.25万 | -250.36%-28.31万 | -91.01%3.84万 | 13.58%-148.55万 | 39.60%-58.69万 | 120.02%18.83万 | 484.32%42.77万 | -113.74%-171.89万 | -118.88%-97.17万 | -285.27%-94.05万 |
| 非经营性净收益 | ||||||||||
| 公允价值变动净收益 | -80.21%64.4万 | -84.15%31.39万 | -65.07%41.86万 | 12.43%99.94万 | 16.91%325.34万 | -3.96%198万 | -25.41%119.82万 | -8.17%88.89万 | 1.51%278.28万 | -21.51%206.16万 |
| 投资净收益 | -2.60%763.21万 | -1.74%555.35万 | 3.58%280.39万 | -21.20%1,687.5万 | 20.00%783.57万 | 24.80%565.19万 | 79.61%270.69万 | 43.43%2,141.5万 | -1.08%652.97万 | 47.01%452.86万 |
| 资产处置收益 | -99.70%149.61 | ---- | ---- | 344.97%5.66万 | 291.55%4.98万 | 291.55%4.98万 | ---- | 42.43%1.27万 | 42.43%1.27万 | --1.27万 |
| 其他收益 | 13.81%436.65万 | -33.57%238.77万 | 72.04%212.76万 | 57.33%419.31万 | 70.30%383.66万 | 1,432.82%359.45万 | 440.47%123.67万 | -48.69%266.51万 | -47.93%225.29万 | 288.43%23.45万 |
| 营业利润 | -20.66%5,917.02万 | -26.28%3,520.1万 | -62.59%527.59万 | 12.47%1.21亿 | 8.29%7,457.8万 | 11.36%4,775.04万 | -15.24%1,410.25万 | 104.18%1.07亿 | 61.86%6,887.01万 | 52.20%4,287.89万 |
| 加:营业外收入 | 39.60%4.64万 | 33.28%4.43万 | 15.40%3.61万 | 1,604.12%30.7万 | 85.22%3.33万 | 89.00%3.33万 | 77.95%3.13万 | -83.09%1.8万 | -77.55%1.8万 | -78.00%1.76万 |
| 减:营业外支出 | 257.44%217.07万 | 4.10%63.11万 | 75,316.50%50.03万 | -14.80%110.88万 | 16.91%60.73万 | 44.56%60.62万 | -99.83%663.43 | -56.03%130.14万 | -76.99%51.94万 | -63.36%41.94万 |
| 利润总额 | -22.92%5,704.6万 | -26.63%3,461.42万 | -65.95%481.17万 | 13.08%1.2亿 | 8.24%7,400.4万 | 11.07%4,717.75万 | -13.10%1,413.32万 | 113.31%1.06亿 | 69.35%6,836.86万 | 56.70%4,247.71万 |
| 减:所得税费用 | 27.12%704.01万 | 85.21%656.45万 | -66.19%91.54万 | -9.65%1,060.85万 | -38.04%553.8万 | -34.31%354.44万 | 0.52%270.76万 | 879.63%1,174.16万 | 3,241.00%893.78万 | 391.23%539.54万 |
| 净利润 | -26.96%5,000.59万 | -35.71%2,804.98万 | -65.90%389.63万 | 15.91%1.09亿 | 15.20%6,846.6万 | 17.67%4,363.31万 | -15.81%1,142.55万 | 84.14%9,439.45万 | 48.20%5,943.08万 | 42.57%3,708.18万 |
| 持续经营净利润 | -26.96%5,000.59万 | -35.71%2,804.98万 | -65.90%389.63万 | 15.91%1.09亿 | 15.20%6,846.6万 | 17.67%4,363.31万 | -15.81%1,142.55万 | 84.14%9,439.45万 | 48.20%5,943.08万 | 42.57%3,708.18万 |
| 减：少数股东损益 | -362.07%-868.75万 | -1,116.42%-714.09万 | -1,521.90%-442.35万 | -691.19%-579.77万 | -345.08%-188.01万 | -170.61%-58.7万 | -651.24%-27.27万 | -1,228.88%-73.28万 | -30.41%-42.24万 | 37.72%-21.69万 |
| 归属于母公司所有者的净利润 | -16.56%5,869.34万 | -20.42%3,519.07万 | -28.88%831.98万 | 21.11%1.15亿 | 17.53%7,034.62万 | 18.56%4,422.01万 | -14.03%1,169.83万 | 85.80%9,512.73万 | 48.05%5,985.33万 | 41.51%3,729.87万 |
| 每股收益 | ||||||||||
| 基本每股收益 | -17.31%0.43 | -21.21%0.26 | -33.33%0.06 | 21.43%0.85 | 18.18%0.52 | 17.86%0.33 | -10.00%0.09 | 84.21%0.7 | 46.67%0.44 | 40.00%0.28 |
| 稀释每股收益 | -15.69%0.43 | -18.75%0.26 | -33.33%0.06 | 20.00%0.84 | 15.91%0.51 | 18.52%0.32 | -10.00%0.09 | 84.21%0.7 | 46.67%0.44 | 35.00%0.27 |
| 其他综合收益 | -116.37%-29.66万 | -88.09%26.26万 | 3,821.35%139.18万 | 10,062.72%128.6万 | 1,932.08%181.19万 | 1,324.59%220.55万 | -79.59%3.55万 | -78.87%1.27万 | 489.22%8.92万 | 15.48万 |
| 归属于母公司所有者的其他综合收益总额 | -116.37%-29.66万 | -88.09%26.26万 | 3,821.35%139.18万 | 10,062.72%128.6万 | 1,932.08%181.19万 | 1,324.59%220.55万 | -79.59%3.55万 | -78.87%1.27万 | 489.22%8.92万 | --15.48万 |
| 综合收益总额 | -29.27%4,970.92万 | -38.23%2,831.23万 | -53.86%528.81万 | 17.25%1.11亿 | 18.07%7,027.79万 | 23.10%4,583.86万 | -16.61%1,146.1万 | 83.95%9,440.72万 | 48.36%5,952万 | 43.16%3,723.66万 |
| 归属于母公司所有者的综合收益总额 | -19.07%5,839.67万 | -23.63%3,545.33万 | -17.23%971.16万 | 22.44%1.16亿 | 20.38%7,215.81万 | 23.96%4,642.56万 | -14.85%1,173.38万 | 85.61%9,514万 | 48.22%5,994.24万 | 42.10%3,745.35万 |
| 归属于少数股东的综合收益总额 | -362.07%-868.75万 | -1,116.42%-714.09万 | -1,521.90%-442.35万 | -691.19%-579.77万 | -345.08%-188.01万 | -170.61%-58.7万 | -651.24%-27.27万 | -1,228.88%-73.28万 | -30.41%-42.24万 | 37.72%-21.69万 |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | 无保留意见 | -- | -- |
| 会计师事务所 | -- | -- | -- | 致同会计师事务所(特殊普通合伙) | -- | -- | -- | 致同会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。